Your Good Partner in Biology Research

重組蛋白

產品名稱 貨號 規(guī)格
Recombinant Yersinia pseudotuberculosis serotype IB 4-deoxy-L-threo-5-hexosulose-uronate ketol-isomerase (kduI) CSB-YP464282YAW
CSB-EP464282YAW
CSB-BP464282YAW
CSB-MP464282YAW
CSB-EP464282YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB S-adenosylmethionine:tRNA ribosyltransferase-isomerase (queA) CSB-YP464283YAW
CSB-EP464283YAW
CSB-BP464283YAW
CSB-MP464283YAW
CSB-EP464283YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB tRNA sulfurtransferase (thiI) CSB-YP464284YAW
CSB-EP464284YAW
CSB-BP464284YAW
CSB-MP464284YAW
CSB-EP464284YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB 50S ribosomal protein L36 1 (rpmJ1) CSB-YP464285YAW
CSB-EP464285YAW
CSB-BP464285YAW
CSB-MP464285YAW
CSB-EP464285YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB UPF0227 protein YPTS_2532 (YPTS_2532) CSB-YP464286YAW
CSB-EP464286YAW
CSB-BP464286YAW
CSB-MP464286YAW
CSB-EP464286YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB N-methyl-L-tryptophan oxidase (solA) CSB-YP464287YAW
CSB-EP464287YAW
CSB-BP464287YAW
CSB-MP464287YAW
CSB-EP464287YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Putative transport protein YPTS_4123 (YPTS_4123), partial CSB-YP464288YAW
CSB-EP464288YAW
CSB-BP464288YAW
CSB-MP464288YAW
CSB-EP464288YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB tRNA uridine 5-carboxymethylaminomethyl modification enzyme MnmG (mnmG), partial CSB-YP464289YAW
CSB-EP464289YAW
CSB-BP464289YAW
CSB-MP464289YAW
CSB-EP464289YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Ribosomal RNA large subunit methyltransferase F (rlmF) CSB-YP464290YAW
CSB-EP464290YAW
CSB-BP464290YAW
CSB-MP464290YAW
CSB-EP464290YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB NADH-quinone oxidoreductase subunit I (nuoI) CSB-YP464291YAW
CSB-EP464291YAW
CSB-BP464291YAW
CSB-MP464291YAW
CSB-EP464291YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Octanoyltransferase (lipB) CSB-YP464292YAW
CSB-EP464292YAW
CSB-BP464292YAW
CSB-MP464292YAW
CSB-EP464292YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Probable nicotinate-nucleotide adenylyltransferase (nadD) CSB-YP464293YAW
CSB-EP464293YAW
CSB-BP464293YAW
CSB-MP464293YAW
CSB-EP464293YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB tRNA 5-methylaminomethyl-2-thiouridine biosynthesis bifunctional protein MnmC (mnmC), partial CSB-YP464294YAW
CSB-EP464294YAW
CSB-BP464294YAW
CSB-MP464294YAW
CSB-EP464294YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB HTH-type transcriptional regulator BetI (betI) CSB-YP464295YAW
CSB-EP464295YAW
CSB-BP464295YAW
CSB-MP464295YAW
CSB-EP464295YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB DNA ligase (ligA), partial CSB-YP464296YAW
CSB-EP464296YAW
CSB-BP464296YAW
CSB-MP464296YAW
CSB-EP464296YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB DnaA-homolog protein hda (hda) CSB-YP464297YAW
CSB-EP464297YAW
CSB-BP464297YAW
CSB-MP464297YAW
CSB-EP464297YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB GTPase Der (der) CSB-YP464298YAW
CSB-EP464298YAW
CSB-BP464298YAW
CSB-MP464298YAW
CSB-EP464298YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Peptidase B (pepB) CSB-YP464299YAW
CSB-EP464299YAW
CSB-BP464299YAW
CSB-MP464299YAW
CSB-EP464299YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Hydroxylamine reductase (hcp), partial CSB-YP464300YAW
CSB-EP464300YAW
CSB-BP464300YAW
CSB-MP464300YAW
CSB-EP464300YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Yersinia pseudotuberculosis serotype IB Integration host factor subunit beta (ihfB) CSB-YP464301YAW
CSB-EP464301YAW
CSB-BP464301YAW
CSB-MP464301YAW
CSB-EP464301YAW-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質形式,可以通過多種方式產生大量蛋白質、修改基因序列和制造有用的商業(yè)產品。重組蛋白的技術資源在重組蛋白的開發(fā)過程中,除了表達系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達載體的選擇、表達蛋白的長度(全長或部分)、是否帶標簽等。在生產重組蛋白時,你必須做出很多決定。如果你選擇的明智,你將獲得高質量的重組蛋白,后續(xù)的實驗更有可能成功。但是如果你做了錯誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質量和純度不符合要求。在這里,來自CUSABIO的蛋白表達工程師根據他們開發(fā)重組蛋白的經驗總結出了幾個有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產,在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產重組蛋白。

第二條:如何選擇合適的表達載體?

表達載體是一種DNA分子,它攜帶特定的基因進入宿主細胞,并利用細胞的蛋白質合成機制來產生由該基因編碼的蛋白質。表達載體可使外源基因在宿主細胞中高效表達,經過多年的發(fā)展,表達載體已成為一種成熟而受歡迎的生物技術。在重組蛋白生產過程中是一種基本成分。正如標題所示,本文主要總結了幾個有用的技巧來選擇合適的表達載體。

第三條:如何表達具有生物活性的蛋白質?

根據重組蛋白的不同應用,對其生物活性有不同的要求。但是我們如何確保蛋白質的產生具有生物活性呢?本文將圍繞這個主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達服務,您可以點擊這里獲取更多信息。注:如果您對CUSABIO的蛋白質有任何疑問,涉及到蛋白質的價格、交貨、質量等,您可以點擊橙色按鈕為我們在線留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>